Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/42452
Arquivos associados a este item:
Não existem arquivos associados a este item.
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorOliveira, André Wagner Carvalho de-
dc.contributor.authorPacheco, Jéssica V. N.-
dc.contributor.authorCosta, Clara de Sena-
dc.contributor.authorAquino, Jéssica-
dc.contributor.authorMaior, Rafael Plakoudi Souto-
dc.contributor.authorBarros, Marilia-
dc.date.accessioned2021-11-25T12:07:11Z-
dc.date.available2021-11-25T12:07:11Z-
dc.date.issued2021-10-16-
dc.identifier.citationOLIVEIRA, André W. C. et al. Scopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeys. Pharmacology Biochemistry and Behavior, v. 21, 173300, dez. 2021. DOI: https://doi.org/10.1016/j.pbb.2021.173300.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/42452-
dc.language.isoInglêspt_BR
dc.publisherElsevier Inc.-
dc.rightsAcesso Restritopt_BR
dc.titleScopolamine and MK-801 impair recognition memory in a new spontaneous object exploration task in monkeyspt_BR
dc.typeArtigopt_BR
dc.subject.keywordSaguipt_BR
dc.subject.keywordMemória de reconhecimentopt_BR
dc.subject.keywordEscopolaminapt_BR
dc.subject.keywordMK-801pt_BR
dc.subject.keywordDonepezilapt_BR
dc.identifier.doihttps://doi.org/10.1016/j.pbb.2021.173300pt_BR
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/abs/pii/S0091305721001994#!pt_BR
dc.description.abstract1The spontaneous object recognition (SOR) task is one of the most widely used behavioral protocols to assess visual memory in animals. However, only recently was it shown that nonhuman primates also perform well on this task. Here we further characterized this new monkey recognition memory test by assessing the performance of adult marmosets after an acute systemic administration of two putative amnesic agents: the competitive muscarinic acetylcholine receptor antagonist scopolamine (SCP; 0.05 mg/kg) and the noncompetitive N-methyl-d-aspartate glutamate receptor antagonist MK-801 (0.015 mg/kg). We also determined whether the acetylcholinesterase inhibitor donepezil (DNP; 0.50 mg/kg), a clinically-used cognitive enhancer, reverses memory deficits caused by either drug. The subjects had an initial 10 min sample trial where two identical neutral objects could be explored. After a 6 h retention interval, recognition was based on an exploratory preference for a new rather than familiar object during a 10 min test trial. Both SCP and MK-801 impaired the marmosets' performance on the SOR task, as both objects were explored equivalently. Co-administration of 0.50 mg/kg of DNP reversed the SCP- but not the MK-801-induced memory deficit. These results indicate that cholinergic and glutamatergic pathways mediate object recognition memory in the monkey SOR task.pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.